Vaxcyte, Inc. - 8-K Filing
Vaxcyte announced Jacks Lee's retirement from the Board effective June 17, 2026. Mr. Lee will serve as a consultant under an agreement related to global strategic supply and manufacturing operations. The company appointed Moncef Slaoui as a Class II director on the same date; Dr. Slaoui is independent per Nasdaq standards and will receive compensation of $430,000 annually in equity grants. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $PCVX